Breaking News
-
Vyome Seals Strategic Pact With Impetis Biosciences, Unlocking a ~$57 Billion Market Horizon
66 0Vyome Partners With Impetis, a TATA Enterprise, to In‑License Next‑Generation…
Read more -
NCLT Hyderabad Clears Resolution Plan: Beaufond Industries to Acquire Kobo Biotech as Going Concern
44 0Landmark approval under IBC, 2016 paves way for Beaufond Industries…
Read more -
Beaufond Plc Charts European Course: Advanced Negotiations Under Way for Strategic API Supply Alliance with Netherlands Pharmaceutical Group
80 0Beaufond PLC’s bold expansion into the Netherlands signals a new…
Read more -
The Architects Of Aesthetics: How India’s Iconic Visionaries are Redefining the Global Skincare Map
52 1The Architects Of Aesthetics: How India’s Iconic Visionaries are Redefining…
Read more -
MSN Labs Disrupts Diabetes Care with SEMABEST: India’s First Fully Integrated Semaglutide Follows Patent Expiry
50 0From API to Pen: MSN Laboratories Challenges Global Giants with…
Read more -
Trump’s Tariff Gambit: Pharma & Metals in the Crossfire of Global Trade
27 1Executive Orders That Redefine Trade Boundaries US President Donald Trump…
Read more -
Ethical Marketing Under Watch: NPPA & MCI Crack Down
35 0From inducements to integrity: Can India’s pharma industry rebuild trust…
Read more -
Vyome Delivers Breakthrough 2025 Performance, Sets Stage for Next Growth Chapter
68 0Vyome is building the world’s premier platform spanning the US-India…
Read more -
Pharma Leaders Power Brand Awards – India’s Most Prestigious Healthcare Leadership Platform
44 1The Pharma Leaders Power Brand Awards, the flagship property of…
Read more -
Is Plastic Surgery Safe? What Patients Should Know Before Considering It
38 0With cosmetic procedures on the rise globally, experts stress that…
Read more

